ScienceMed®

Davos@home: Integrando o monitoramento domiciliar objetivo no apoio à autogestão em eHealth após o tratamento climático de altitude alpina para asma grave

Imunologia e Alergia
Imagem de arquivo, ilustrativa — não é do estudo. Radiografia de tórax de pulmões saudáveis. N.a. Radiology by Dr. Johan Verbeken. Scan and image editing by Vincent Mia Edie Verheyen · domínio público · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaRespiratory medicine1 out 20260 citações

Salvar

Resumo original em inglês

O que aconteceu

Severe asthma imposes substantial burden, and many patients remain uncontrolled despite guideline-based therapy. Alpine Altitude Climate Treatment (AACT) improves asthma control and quality of life, yet benefits often attenuate after returning home. eHealth-supported self-management may help sustain AACT gains and prevent post-rehabilitation relapse, though the added value of objective home monitoring devices remains unclear.

In this 12-month pragmatic trial, adults with severe asthma completing AACT in Davos were randomised to eHealth self-management support with or without home monitoring devices measuring airway inflammation, lung function and activity. Randomisation was stratified by baseline fractional exhaled nitric oxide (FeNO; <25 vs ≥ 25 ppb). The pre-specified primary outcome was time-to-first severe exacerbation; secondary outcomes included annualised exacerbation and hospitalisation rates and patient-reported outcomes.

O que encontraram

Between 2022 and 2024, 143 patients were randomised; 130 received the allocated intervention (66 intervention, 64 control), and 105 completed follow-up. Time-to-first severe exacerbation did not differ between groups (median [IQR] intervention: 16.5 [13-23], control: 20 [16-30] weeks; log-rank p = 0.93). There was a non-significant trend toward fewer annualised severe exacerbations in the intervention group (aRR 0.68, 95%CI 0.45-1.03; p = 0.07). Slower ACQ-6 decline (baseline-6 months) was observed in the intervention group (β -0.50, 95%CI -0.95;-0.05; p = 0.03), though this did not persist to 12 months. No effect modification by FeNO strata was observed; no intervention-related serious adverse events occurred.

Por que isso importa

Adding home monitoring devices to eHealth self-management did not prolong time-to-first severe exacerbation or sustain clinical benefits after AACT. More personalised, clinically integrated strategies could support the transition to independent self-management.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Davos@home: Integrating objective home monitoring into eHealth self-management support after alpine altitude climate treatment for severe asthma

Fleur L Meulmeester, Femke Paanakker, Lianne Ten Have, Kim de Jong, Anneke Ten Brinke, Jacob K Sont, Karin B Fieten

Descritores MeSH

  • Self-Management
  • Altitude
  • Asthma
  • Telemedicine
  • Adult
  • Quality of Life
  • Severity of Illness Index
  • Female
  • Humans
  • Male

Veja também